Lassen Therapeutics
Founded 2019 · 10 employees on LinkedIn · 9 known investors
Find your way into Lassen Therapeutics
535 people in our graph share verified history with the Lassen Therapeutics team — schools, employers, funds. One of them is your warm intro.
Deep Nisharunlockedknows Maria Fardis · together at University of Illinois Urbana-Champaign (overlapped)
×2knows the team · via University of Illinois Urbana-Champaign
×6knows the team · via University of California, Berkeley
×3knows the team · via Golden Gate University
Lassen Therapeutics is a biotechnology company developing therapeutics targeting IL-11, with a pipeline focused on immune and fibrotic diseases.
Founders & leadership
Lassen Therapeutics was founded in 2019 by David King.
DK
David KinginCo-Founder & CSOCo-founder and Chief Scientific Officer of Lassen Therapeutics, a biotech company developing therapeutics targeting IL-11 for immune and fibrotic diseases. King has prior experience in biologics and antibody discovery across multiple biotech companies and contributed to the development of FDA-approved therapeutics.
MF
CC
Cadmus C. RichinChief Medical Officer
ES
Elaine StrackerinGeneral Counsel
Investors · 9
Alta PartnersJackson · $1M – $12M
Catalio Capital Management, LPNew York
DC Investment PartnersMcLean · $10M
Longitude CapitalMenlo Park · $10M – $30M
Longwood FundBoston
Biotechnology Value FundreportedSan Francisco
Catalio Capital ManagementreportedNew York
Frazier Healthcare PartnersreportedSeattle · $50M – $400M
Frazier Life SciencesreportedPalo Alto
Funding
SEC filings, press & company announcements$85M disclosed across 1 of 2 rounds · 2023–2024
- Undisclosed amountSeries BJan 2024
Frazier Life Sciences (lead), Longitude Capital (lead), Alta Partners, BVF Partners, Catalio Capital Management, Longwood Fund
Source ↗ - $85MSeries BDec 2023 · 2 sourcesSource ↗
Source: company announcements and press reports — follow each round's link for the claim.
Founder mafia
2 people who came through Lassen Therapeutics went on to found or lead other companies.
In the news
Frequently asked questions
- What does Lassen Therapeutics do?
- Lassen Therapeutics is a biotechnology company developing therapeutics targeting IL-11, with a pipeline focused on immune and fibrotic diseases.
- Who founded Lassen Therapeutics?
- Lassen Therapeutics was founded by David King in 2019.
- Who are Lassen Therapeutics's investors?
- Lassen Therapeutics's investors include Alta Partners, Catalio Capital Management, LP, DC Investment Partners, Longitude Capital, Longwood Fund, Biotechnology Value Fund, Catalio Capital Management, Frazier Healthcare Partners and 1 more.
- How much funding has Lassen Therapeutics raised?
- Lassen Therapeutics has disclosed $85M raised across 1 of its 2 known rounds.